Pharmaceutical

Scottish company secures £4.2m to advance 3D-printed micro-tumour tech

Carcinotech has gained funding to enter the North American market with the company's pioneering 3D-printed tumours for cancer treatments.

Feb 2, 2024 - 18:00
Scottish company secures £4.2m to advance 3D-printed micro-tumour tech
Carcinotech has gained funding to enter the North American market with the company's pioneering 3D-printed tumours for cancer treatments.
Read the original article

Tags:

Previous Article

As England’s virus hospitalisations surge flu vaccines evolve

Next Article

LimmaTech secures funding for vaccine technology development

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Startup BioAge raises $170 million Series D for Zepbound combination therapy

STAT+: Startup BioAge raises $170 million Series D for ...

Feb 13, 2024

STAT+: This chemist’s last startup sold for $4 billion. Now investors have poured $173 million into her next act

STAT+: This chemist’s last startup sold for $4 billion....

Feb 29, 2024

Roche buys worldwide rights to Zion Pharma’s ZN-A-1041

Roche buys worldwide rights to Zion Pharma’s ZN-A-1041

May 10, 2023